FR2532310B1 - Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- FR2532310B1 FR2532310B1 FR8313590A FR8313590A FR2532310B1 FR 2532310 B1 FR2532310 B1 FR 2532310B1 FR 8313590 A FR8313590 A FR 8313590A FR 8313590 A FR8313590 A FR 8313590A FR 2532310 B1 FR2532310 B1 FR 2532310B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- benzamide derivatives
- novel benzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8224296 | 1982-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2532310A1 FR2532310A1 (fr) | 1984-03-02 |
FR2532310B1 true FR2532310B1 (fr) | 1986-01-10 |
Family
ID=10532494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8313590A Expired FR2532310B1 (fr) | 1982-08-24 | 1983-08-23 | Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (23)
Country | Link |
---|---|
US (1) | US4507315A (fr) |
JP (1) | JPS5955873A (fr) |
KR (1) | KR840005717A (fr) |
AT (1) | ATA301083A (fr) |
AU (1) | AU1818083A (fr) |
BE (1) | BE897580A (fr) |
CA (1) | CA1195993A (fr) |
CS (1) | CS240973B2 (fr) |
DE (1) | DE3330403A1 (fr) |
DK (1) | DK386783A (fr) |
ES (2) | ES525099A0 (fr) |
FI (1) | FI832989A (fr) |
FR (1) | FR2532310B1 (fr) |
GB (1) | GB2126225B (fr) |
GR (1) | GR78673B (fr) |
IL (1) | IL69544A0 (fr) |
IT (1) | IT1169775B (fr) |
LU (1) | LU84974A1 (fr) |
NL (1) | NL8302947A (fr) |
NO (1) | NO833024L (fr) |
PT (1) | PT77219B (fr) |
SE (1) | SE8304545L (fr) |
ZA (1) | ZA836191B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0625144B2 (ja) * | 1986-02-24 | 1994-04-06 | 四国化成工業株式会社 | 新規イミダゾール化合物及び該化合物の合成方法 |
US4916145A (en) * | 1987-07-10 | 1990-04-10 | Hoffmann-La Roche Inc. | Substituted n-[(pyridyl)alkyl]aryl-carboxamide |
US4886629A (en) * | 1988-06-06 | 1989-12-12 | Allied-Signal Inc. | Process for the preparation of fluorinated benzene sulfonyl fluorides |
CA2057324A1 (fr) * | 1990-12-18 | 1992-06-19 | Lora Louise Fitch | Agents hypoglycemiques de type benzamide et sulfonamide |
US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
AU5912800A (en) * | 1999-07-06 | 2001-01-22 | Vertex Pharmaceuticals Incorporated | Beta-amino acid derivatives for the treatment of neurological diseases |
DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
MX2007003623A (es) | 2004-09-24 | 2007-09-11 | Johnson & Johnson | Compuestos sulfonamida. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3349124A (en) * | 1957-05-20 | 1967-10-24 | Pfizer & Co C | Oral antidiabetic agent |
BE756062A (fr) * | 1969-09-11 | 1971-03-11 | Boehringer Sohn Ingelheim | Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides |
DE2500157C2 (de) * | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
DE2517229A1 (de) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung |
DK148576A (da) * | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
US4317915A (en) * | 1976-08-23 | 1982-03-02 | Hoffmann-La Roche Inc. | Novel thiophene derivatives |
NZ186175A (en) * | 1977-01-27 | 1980-03-05 | Shionogi & Co | Meta-sulphonamidobenzamide derivatives |
US4245120A (en) * | 1977-09-27 | 1981-01-13 | American Cyanamid Company | 4-(Monoalkylamino)benzene polycarboxylic acids |
LU79008A1 (de) * | 1978-02-03 | 1979-09-06 | Byk Gulden Lomberg Chem Fab | W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel |
-
1983
- 1983-08-18 PT PT77219A patent/PT77219B/fr unknown
- 1983-08-22 ZA ZA836191A patent/ZA836191B/xx unknown
- 1983-08-22 KR KR1019830003923A patent/KR840005717A/ko not_active Application Discontinuation
- 1983-08-22 GB GB08322539A patent/GB2126225B/en not_active Expired
- 1983-08-22 IL IL69544A patent/IL69544A0/xx unknown
- 1983-08-22 SE SE8304545A patent/SE8304545L/xx not_active Application Discontinuation
- 1983-08-22 GR GR72271A patent/GR78673B/el unknown
- 1983-08-22 NO NO833024A patent/NO833024L/no unknown
- 1983-08-22 CS CS836124A patent/CS240973B2/cs unknown
- 1983-08-22 AU AU18180/83A patent/AU1818083A/en not_active Abandoned
- 1983-08-22 JP JP58151746A patent/JPS5955873A/ja active Pending
- 1983-08-22 FI FI832989A patent/FI832989A/fi not_active Application Discontinuation
- 1983-08-22 US US06/525,503 patent/US4507315A/en not_active Expired - Fee Related
- 1983-08-23 BE BE0/211394A patent/BE897580A/fr not_active IP Right Cessation
- 1983-08-23 AT AT833010A patent/ATA301083A/de not_active Application Discontinuation
- 1983-08-23 NL NL8302947A patent/NL8302947A/nl not_active Application Discontinuation
- 1983-08-23 CA CA000435172A patent/CA1195993A/fr not_active Expired
- 1983-08-23 ES ES525099A patent/ES525099A0/es active Granted
- 1983-08-23 LU LU84974A patent/LU84974A1/fr unknown
- 1983-08-23 DK DK386783A patent/DK386783A/da unknown
- 1983-08-23 DE DE19833330403 patent/DE3330403A1/de not_active Withdrawn
- 1983-08-23 FR FR8313590A patent/FR2532310B1/fr not_active Expired
- 1983-08-24 IT IT22629/83A patent/IT1169775B/it active
- 1983-12-13 ES ES528012A patent/ES528012A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ZA836191B (en) | 1984-04-25 |
PT77219B (fr) | 1986-02-04 |
GB8322539D0 (en) | 1983-09-21 |
ES8502691A1 (es) | 1985-01-16 |
IT1169775B (it) | 1987-06-03 |
ES525099A0 (es) | 1985-01-16 |
GR78673B (fr) | 1984-09-27 |
CS612483A2 (en) | 1985-06-13 |
GB2126225B (en) | 1985-10-09 |
LU84974A1 (fr) | 1984-03-23 |
PT77219A (fr) | 1983-09-01 |
FI832989A (fi) | 1984-02-25 |
ES8505935A1 (es) | 1985-06-16 |
DE3330403A1 (de) | 1984-03-01 |
IL69544A0 (en) | 1983-11-30 |
US4507315A (en) | 1985-03-26 |
FI832989A0 (fi) | 1983-08-22 |
SE8304545L (sv) | 1984-02-25 |
AU1818083A (en) | 1984-03-01 |
SE8304545D0 (sv) | 1983-08-22 |
JPS5955873A (ja) | 1984-03-31 |
ATA301083A (de) | 1985-11-15 |
IT8322629A0 (it) | 1983-08-24 |
NL8302947A (nl) | 1984-03-16 |
FR2532310A1 (fr) | 1984-03-02 |
DK386783A (da) | 1984-02-25 |
DK386783D0 (da) | 1983-08-23 |
BE897580A (fr) | 1984-02-23 |
GB2126225A (en) | 1984-03-21 |
ES528012A0 (es) | 1985-06-16 |
CS240973B2 (en) | 1986-03-13 |
CA1195993A (fr) | 1985-10-29 |
KR840005717A (ko) | 1984-11-16 |
NO833024L (no) | 1984-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2676446B1 (fr) | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2665159B1 (fr) | Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2642069B1 (fr) | Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2599742B1 (fr) | Composes antibiotiques, leur preparation et les compositions pharmaceutiques qui les contiennent | |
BE888389A (fr) | Acrylamido-cephalosporines omega, beta-disubstituees leur preparation et compositions pharmaceutiques en contant, | |
BE838194A (fr) | Nouveaux derives de l'oxadiazolinone, leur preparation et les compositions qui les contiennent | |
FR2687151B1 (fr) | Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
BE869261A (fr) | Nouveaux derives de la pepstatine, leur preparation et les compositions qui les contiennent | |
FR2557111B1 (fr) | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent | |
FR2602771B1 (fr) | Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2532310B1 (fr) | Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2574407B1 (fr) | Nouveaux derives de la pyrrolo(2,3-d) pyrimidine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
IT8424159A0 (it) | Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione. | |
BE889497A (fr) | Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent | |
LU81182A1 (fr) | Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent | |
LU78895A1 (fr) | Nouveaux derives de l'isoquinoleine,leur preparation et les compositions qui les contiennent | |
BE869485A (fr) | Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent | |
FR2521142B1 (fr) | Nouveaux derives n-methanesulfonique de la demethyl-3-o istamycine b, leur preparation et compositions therapeutiques en contenant | |
BE877555A (fr) | Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
BE863083A (fr) | Nouveaux derives de l'isoquinoleine, leur preparation et les compositions qui les contiennent | |
BE867129A (fr) | Nouveaux derives de l'hydroxy-4 thiazolidinethione-2, leur preparation et les compositions qui les contiennent | |
LU80497A1 (fr) | Nouveaux derives de l'isoquinoleine,leur preparation et les compositions qui les contiennent | |
FR2644458B1 (fr) | Nouveaux complexes derives du platine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
BE896465A (fr) | Nouveaux derives du benzimidazole, leur preparation et les medicaments qui les contiennent | |
BE883191A (fr) | Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |